Comprehensive Tumor Ablation Therapy Devices Market Forecast 2025-2034: Growth Trends and Strategic Shifts

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Tumor Ablation Therapy Devices Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for tumor ablation therapy devices has witnessed swift expansion in recent times. The market is projected to develop from a worth of $0.72 billion in 2024 to approximately $0.83 billion in 2025, displaying a compound annual growth rate (CAGR) of 15.0%. The increased prevalence of cancer, advancements in technology, an aging demographic group, and the growing preference for minimally invasive methods contribute to the growth experienced in the historic period.

Tumor Ablation Therapy Devices Market Size Forecast: What's the Projected Valuation by 2029?
The market for tumor ablation therapy devices is anticipated to significantly expand in the coming years. It's projected to reach $1.44 billion in 2029, with a compound annual growth rate (CAGR) of 14.8%. Factors contributing to this projected growth during the forecast period include personalized medicine, combined treatments, advancements in AI and image-guided ablation, telemedicine, as well as remote consultations and training. The forecast period is also poised to see critical trends such as developments in ablation technologies, guided imagery, robotic assistance, navigation assistance, as well as integration with immuno-oncology, and image-guided and percutaneous ablation.

View the full report here:
https://www.thebusinessresearchcompany.com/report/tumor-ablation-therapy-devices-global-market-report

What Are the Drivers Transforming the Tumor Ablation Therapy Devices Market?
The tumor ablation therapy devices market is expanding due to the increasing incidences of cancer, which is the second leading cause of mortality worldwide, with around 1 in 6 global deaths caused by it. Tumor ablation, a minimally invasive technique widely used to treat lung, liver, kidney, and bone tumors, is gaining traction. For example, the American Cancer Society Inc., a non-profit health group in the US, predicts 1,958,310 new diagnoses of cancer in the United States in 2023. This is a spike from the over 1,918,030 new cases recorded in 2022. Patients who did not respond positively to chemotherapy or radiotherapy find this procedure beneficial, further bolstering the growth of the tumor ablation therapy devices market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3351&type=smp

What Long-Term Trends Will Define the Future of the Tumor Ablation Therapy Devices Market?
Several leading companies in the tumor ablation therapy device sector, such as J&J Medicals, are concentrating on technological innovations that enable more streamlined procedures, improved safety, reduced radiation exposure, quicker learning periods, and better patient outcomes. For example, J&J Medicals developed a microwave ablation device named NEUWAVE - this revolutionary device is the first minimally invasive technology that introduces electrodes into cancerous cells, subsequently raising ambient temperatures to effectively eradicate these cells. In another development in April 2023, Taiwan's Compal Electronics introduced their new radiofrequency ablation (RFA) system, AblatePal. This system, designed specifically for intraoperative coagulation and soft tissue ablation, also covers partial to full treatment of non-removable liver lesions. The AblatePal system works by harnessing the heat generated from electrical resistance as currents pass through tissues, resulting in the targeted removal of specific tissues. The system is applicable in the context of therapeutic medical devices, and has been designed to tackle numerous medical conditions, most notably cancer.

Which Segments in the Tumor Ablation Therapy Devices Market Offer the Most Profit Potential?
The tumor ablation therapy devices market covered in this report is segmented -

1) By Technology: Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation, Other Technologies
2) By Treatment: Surgical, Laparoscopic, Percutaneous
3) By Application: Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Other Applications
4) By End User: Hospitals, Oncology Clinics, Other End Users

Subsegments:
1) By Radiofrequency Ablation (RFA): Monopolar RFA Devices, Bipolar RFA Devices
2) By Microwave Ablation: High-frequency Microwave Devices, Low-frequency Microwave Devices
3) By Cryoablation: Liquid Nitrogen-based Devices, Argon Gas-based Devices
4) By Irreversible Electroporation Ablation (IRE): NanoKnife Ablation Systems, High-voltage Pulse Generators
5) By Other Technologies: Laser Ablation Devices, Ultrasound-guided High-intensity Focused Ultrasound (HIFU), Chemical Ablation Techniques

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=3351&type=smp

Which Firms Dominate the Tumor Ablation Therapy Devices Market by Market Share and Revenue in 2025?
Major companies operating in the tumor ablation therapy devices market include Galil Medical Inc., Misonix Inc., HealthTronics Inc., AngioDynamics Inc., Boston Scientific Corporation, Medtronic plc, EDAP TMS S.A., NeuWave Medical Inc., BVM Medical Limited, Erbe Elektromedizin GmbH, AtriCure Inc., Theraclion, INTIO Inc., BIOTRONIK SE & Co. KG, Olympus Corporation, Stryker Corporation, Merit Medical Systems Inc., Insightec Ltd., Terumo Corporation, Smith & Nephew plc, Monteris Medical Corporation, IceCure Medical Ltd., Profound Medical Inc., Alpinion Medical Systems Co. Ltd., Sonacare Medical, Hologic Inc., Endocare Inc., Integra LifeSciences Corporation, Bovie Medical Corporation

Which Regions Offer the Highest Growth Potential in the Tumor Ablation Therapy Devices Market?
North America was the largest region in the tumor ablation therapy devices market in 2023. Asia-Pacific was the second largest region in the tumor ablation therapy devices market. The regions covered in the tumor ablation therapy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3351

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.